• 關於安成About Us
    • Company Profile
    • Management Team
    • Milestones
    • Plant & Quality
    • Join Us
    • Contact
  • Products
  • 研究與發展Research & Development
    • High Barrier Generics
  • 投資人關係
    • Shareholder Services
    • Corporate Governance
    • Unaudited Monthly Sales
    • Financial Report
    • Shareholder Contacts
  • 新聞發佈News & Media
    • News
    • Announcement

News

Announcement

Home > News & Media > News
Communication starts here.
2013.10
TWi Pharmaceuticals, Inc. Comments on Dexilant® Ruling
2013.7
TWi Pharmaceuticals Receives Patent Allowance for Its Reduced Food Effect Metformin Controlled Release Formulation in United States
2013.06
TWi Biotechnology Announces Completion of Patient Enrollment in Gout Flare Prophylaxis Phase II Trial for AC-201
2013.05
TWi Pharmaceuticals Announces Tentative ANDA Approval for Guanfacine Hydrochloride Extended-Release Tablets

 

Pages:1 - 2 - 3 - 4 - 5 - 6 - 7« Pre · Next »

©Copyright 2013 安成國際藥業股份有限公司版權所有